can i mix tirzepatide and semaglutide Troubling Findings in Study of GLP-1 Compounders What to Eat on GLP-1

(PubMed) Harris HR, Orsini N, Wolk A

In the first half of 2025, AI-enabled healthcare startups captured 62% of all digital health venture funding in the US, raising an average of $34.4 million per round an 83% premium over non-AI startups

Nivolumab (NIVO) + low-dose ipilimumab (IPI) in previously treated patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Long-term follow-up

For this demographic, the decision to start treatment requires careful consideration and close monitoring by a healthcare provider

The primary side effects are gastrointestinal symptoms including bloating, abdominal discomfort, loose stools, and diarrhoea, particularly at doses exceeding 0.40.5 grams per kilogram of body weight per day